<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The cyclin-dependent kinase (cdk) inhibitor, p57 (Kip2) is a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor candidate and a paternally-imprinted gene </plain></SENT>
<SENT sid="1" pm="."><plain>In humans, the p57(Kip2) gene is located on chromosome 11p15.5, a region implicated in both <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>From analysis of p57(Kip2)-deficient mice, we demonstrate the relationship between trophoblastic abnormalities and p57(Kip2) </plain></SENT>
<SENT sid="3" pm="."><plain>Both p57(Kip2) null ((-/-)) embryos and heterozygous embryos with a maternally-derived mutated allele ((+*/-)) displayed placentomegaly, as well as <z:mpath ids='MPATH_589'>dysplasia</z:mpath> of labyrinthine and spongiotrophoblasts </plain></SENT>
<SENT sid="4" pm="."><plain>The number of labyrinthine trophoblasts of homozygous embryos was twice that in <z:mp ids='MP_0002169'>wild-type</z:mp> embryos </plain></SENT>
<SENT sid="5" pm="."><plain>When we measured kinase activities of cdk in total placenta lysates by the immuno complex kinase assay, there were no differences among the genotypes </plain></SENT>
<SENT sid="6" pm="."><plain>These results show that p57(Kip2) may function in the proper development of labyrinthine and spongiotrophoblasts by pathways that are not involved with regulation of cdk activities </plain></SENT>
<SENT sid="7" pm="."><plain>It is, therefore, suggested that p57(Kip2) protein might have an unknown role </plain></SENT>
</text></document>